The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

His mother, Amberlie Reinertsen, says Mason has had lung complications since birth but has never been this sick before.

The number of local emergency department visits for respiratory illnesses in Broome County has changed since the beginning of ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

UPMC saw an increase in RSV cases in its health system, including in Lancaster County, a spokesperson said Jan. 7, especially ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

The 30-day risk for death was slightly higher for COVID-19 than for influenza or RSV; the 180-day mortality also was higher for COVID-19.

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.